RMC No. 34-2019: Input Tax Reporting Rules for VAT-Exempt Diabetes, High-Cholesterol, and Hypertension Medicines

RMC No. 34-2019 explains how sellers of VAT-exempt diabetes, cholesterol, and hypertension medicines must inventory stocks and adjust input tax. Manufacturers, wholesalers, distributors, and retailers holding unsold diabetes, high-cholesterol, and hypertension medicines as of December 31, 2018 had to inventory those medicines and adjust the related input VAT once the medicines became VAT-exempt beginning January […]